THE MEDICAL NEWS |
Popis: from News-Medical.Net - Latest Medical News and Research from Around the World
|
||||||
Stanford study challenges long-held dogma on causes of concussions16:27 Concussions - essentially mild traumatic brain injuries - are among the most common injuries sustained on athletic fields. In the U.S., an estimated 3.8 million sports-related concussions occur every year. New monoclonal antibody therapy significantly lowers patient triglyceride levels16:27 A phase 2b clinical trial led by Mass General Brigham Heart and Vascular Institute researchers shows that a monoclonal antibody therapy called MAR001 can significantly reduce triglyceride levels within 12 weeks for patients with high triglyceride levels. Could a daily supplement keep blood vessels healthier as we age?15:53 The study highlights a multi-compound nutritional supplement's potential to improve blood vessel function and lower blood pressure, aiding vascular health. Intravenous blood thinner improves heart recovery after cardiogenic shock13:00 For heart attack patients who develop cardiogenic shock-the most serious complication of a heart attack-cangrelor, a potent intravenous blood thinner, resulted in better recovery of heart function when compared to oral antiplatelet therapy. New mRNA therapy reawakens heart muscle cells to repair damage13:00 Scientists have developed a treatment that 'reawakens' heart muscle cells so they start to divide and help repair damaged muscle. AI tool uses emergency room narratives to predict PTSD risk12:23 An AI tool can analyze patients' narratives about injuries that sent them to the emergency room to predict who will later develop post-traumatic stress disorder (PTSD), a new study found. Alliance highlights clinical trials advancing lung cancer detection and care12:23 Lung cancer remains the leading cause of cancer-related deaths in the United States, but advances in early detection and treatment are improving the outlook for patients. Qureight's fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical12:23 Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight's Fibr8™ quant… Better reimbursement programs can improve access to cancer clinical trials12:23 New research reveals that participating in cancer clinical trials can cause financial burdens that are shaped by both socioeconomic and logistical factors. Modified zinc finger protein reduces brain plaques in Alzheimer's mice12:23 A KAIST-led research team has found that a protein involved in gene regulation can suppress the harmful aggregation of amyloid-beta, a peptide associated with Alzheimer's disease. |
Noviny
Sépie
Černé
Konzole
Modré
Přihlásit
Založit účet
Souhrn
Moje
Home
World
Sport
Economy
Technology
Culture
Life & Style
Other